We've provided comments to USP acknowledging that proposed standards for the in-office compounding of extracts are reasonable and acceptable.
An advisory was issued from the Centers for Medicare and Medicaid Services.
The College and Academy leadership met with CMS to express serious concerns about the proposed 2019 reductions in Medicare reimbursement.
Advocacy Council of the ACAAI to oppose proposed 2019 Medicare payment reductions for allergy/immunologyCMS has released the proposed Medicare Physician Fee Schedule Rule for 2019, which includes substantial Medicare payment reductions for A/I.
Some of allergy's top leaders converged on Washington, DC to advocate for issues important to you and your patients.
This joint statement by iCAALL calls attention to the impact and relevance of allergy specialists.
ALK will no longer supply venom extracts in the U.S.
Joint advocacy efforts are successful.
Make sure your practice is ready on April 1.